The acute effect of metabolic cofactor supplementation: a potential therapeutic strategy against non‐alcoholic fatty liver disease-Reference-Cited by-同舟云学术

The acute effect of metabolic cofactor supplementation: a potential therapeutic strategy against non‐alcoholic fatty liver disease

Published:2020-04 Issue:4 Volume:16 Page:
ISSN:1744-4292
Container-title:Molecular Systems Biology
language:en
Short-container-title:Mol Syst Biol

Author:

Zhang Cheng¹²^ORCID,Bjornson Elias³⁴,Arif Muhammad¹,Tebani Abdellah¹^ORCID,Lovric Alen¹,Benfeitas Rui¹^ORCID,Ozcan Mehmet¹^ORCID,Juszczak Kajetan¹,Kim Woonghee¹,Kim Jung Tae¹,Bidkhori Gholamreza⁵,Ståhlman Marcus³,Bergh Per‐Olof³^ORCID,Adiels Martin³,Turkez Hasan⁶,Taskinen Marja‐Riitta⁷,Bosley Jim⁸,Marschall Hanns‐Ulrich³,Nielsen Jens⁴^ORCID,Uhlén Mathias¹^ORCID,Borén Jan³^ORCID,Mardinoglu Adil¹⁵^ORCID

Affiliation:

1. Science for Life Laboratory KTH—Royal Institute of Technology Stockholm Sweden

2. School of Pharmaceutical Sciences Zhengzhou University Zhengzhou China

3. Department of Molecular and Clinical Medicine University of Gothenburg and Sahlgrenska University Hospital Gothenburg Gothenburg Sweden

4. Department of Biology and Biological Engineering Chalmers University of Technology Gothenburg Sweden

5. Centre for Host‐Microbiome Interactions Faculty of Dentistry, Oral & Craniofacial Sciences King's College London London UK

6. Department of Medical Biology Faculty of Medicine Atatürk University Erzurum Turkey

7. Research Programs Unit, Diabetes and Obesity Department of Internal Medicine Helsinki University Hospital University of Helsinki Helsinki Finland

8. Clermont, Bosley LLC Gothenburg Sweden

Funder

Knut och Alice Wallenbergs Stiftelse

Hjärt-Lungfonden

Publisher

EMBO

Subject

Applied Mathematics,Computational Theory and Mathematics,General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,Information Systems

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/msb.209495

Reference38 articles.

1. An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers

2. Informing pharmacokinetic models with physiological data: oral population modeling of L‐serine in humans;Bosley J;medRxiv,2019

3. Improving the economics of NASH/NAFLD treatment through the use of systems biology

4. Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards personalized genome-scale modeling of inborn errors of metabolism for systems medicine applications;Metabolism;2024-01

2. Data-driven transcriptomics analysis identifies PCSK9 as a novel key regulator in liver aging;GeroScience;2023-09-20

3. Longitudinal metabolomics analysis reveals the acute effect of cysteine and NAC included in the combined metabolic activators;Free Radical Biology and Medicine;2023-08

4. The acute effect of different NAD+ precursors included in the combined metabolic activators;Free Radical Biology and Medicine;2023-08

5. What is really known about the effects of nicotinamide riboside supplementation in humans;Science Advances;2023-07-21